Back to Results
First PageMeta Content
Health / Advocacy groups / European Federation of Pharmaceutical Industries and Associations / Pharmaceuticals policy / European Medicines Agency / Pharmaceutical industry / Medical device / Medicine / Pharmaceutical sciences / Clinical research


Public Consultation on a possible revision of Council Directive Respondent profile Please indicate the type of organisation on behalf of which you are responding to this Pharmaceutical company – originator products
Add to Reading List

Document Date: 2012-10-18 13:28:05

Open Document

File Size: 59,48 KB

Share Result on Facebook

Company

Amgen / /

Continent

Europe / /

Country

Germany / Norway / Belgium / France / Netherlands / Iceland / Italy / Portugal / Bulgaria / United Kingdom / Sweden / Denmark / /

IndustryTerm

soft-law instrument / biotech products / soft law instrument / biological medicinal products / health technology / originator products / reimbursement applications / certain medicinal products / case-law / pharmaceutical industry / identified products / biotechnology products / soft law approach / law relating / medicinal product / non-equivalent products / todeliver innovative products / public procurement law / medicinal products / technology assessment / auto-injector devices / /

Organization

EFPIA / Court of Justice / European Medicines Agency / European Commission / European Union / /

Position

representative / /

Product

Vectibix / /

ProvinceOrState

Mississippi / /

Technology

health technology / biotechnology / chemotherapy / /

SocialTag